Clinical trials: Central Serous Retinopathy (CSR)
Central Serous Chorioretinopathy
Subthreshold Nanosecond Laser for Non-resolving Central Serous Chorioretinopathy
This is a prospective, multicentre, sham-controlled, participant- and assessor-masked superiority trial with two parallel treatment arms which aims to investigate the safety and efficacy of subthreshold nanosecond laser (SNL) in…
- Trial name
- NANO-C (NCT05570591)
- Testing
- 2RT subthreshold nanosecond laser - active
- Where
- 2 sites in Australia
- Volunteers
- 60 people
- Sponsor
- Nova Eye Medical Pty Ltd.